Evidence map›Paper›PMID 28229380›Full record

ArticleMetabolic brain disease2017

Cognitive impairment is correlated with insulin resistance degree: the "PA-NICO-study".

Antonietta Fava, Carmen Colica, Massimiliano Plastino, Demetrio Messina, Dario Cristiano, Carlo Opipari, Antonio Vaccaro, Gaetano Gorgone, Francesca Bosco, Alessandra Fratto and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. The Effects ofNutrients · 2023
    Review
  7. Insulin resistance, cognition, and Alzheimer disease.Obesity (Silver Spring, Md.) · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Antonietta FavaDepartment of Clinical and Experimental Medicine, University of Catanzaro, 88100, Catanzaro, Italy.
Carmen ColicaInstitute of Neurological Science - National Research Council, Roccelletta di Borgia, 88100, Catanzaro, Italy.
Massimiliano PlastinoDepartment of Neuroscience, "S. Giovanni di Dio" Hospital, Largo Bologna, 88900, Crotone, Italy.
Demetrio MessinaDepartment of Neuroscience, "S. Giovanni di Dio" Hospital, Largo Bologna, 88900, Crotone, Italy.
Dario CristianoDepartment of Neuroscience, "S. Giovanni di Dio" Hospital, Largo Bologna, 88900, Crotone, Italy.
Carlo OpipariDepartment of Neuroscience, "S. Giovanni di Dio" Hospital, Largo Bologna, 88900, Crotone, Italy.
Antonio VaccaroDepartment of Neuroscience, "S. Giovanni di Dio" Hospital, Largo Bologna, 88900, Crotone, Italy.
Gaetano GorgoneDepartment of Neuroscience, "S. Giovanni di Dio" Hospital, Largo Bologna, 88900, Crotone, Italy.
Francesca BoscoUniversity of Pharmacology, loc. Roccelletta, University "Magna Graecia", 88100, Catanzaro, Italy.
Alessandra FrattoDepartment of Neuroscience, "S. Giovanni di Dio" Hospital, Largo Bologna, 88900, Crotone, Italy.
Matteo De BartoloService of Neurophysiology, Hospital, 87067, Rossano, Italy.
Domenico BoscoDepartment of Neuroscience, "S. Giovanni di Dio" Hospital, Largo Bologna, 88900, Crotone, Italy. nico_bosco@libero.it.
Nuovo Ospedale San Giovanni di Dio · ITMagna Graecia University · ITNational Research Council · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several epidemiological studies have shown that Diabetes Mellitus (DM) or Insulin Resistance (IR) increases the risk of dementia. Besides, some authors suggested that poor glucose control to be associated with worse cognitive function. We aimed to assess cognitive functions and IR-degree over time in diabetic. We also evaluated whether a greater magnitude of cognitive decline could be related with their IR degree. We enrolled 335 diabetic patients and 142 non-diabetic subjects; participants were subdivided into three groups in accordance with their IRdegree assessed by Homa-Index (HI): Normal-HI (non-diabetic NHI < 2,6), Moderate-HI (MHI > 2,6 < 10) and High-HI (HHI > 10). Metabolic status and a comprehensive neuropsycological test battery (MMSE, ADAS-Cog, ACDS-ADL) were assessed at baseline and every 12-months during the follow-up (6,8 years). At the end of the study, the average MMSE decreased significantly in patients of HHI group (P = .001) compared to baseline. MMSE scores were also reduced both in MHI group and in controls, but the difference between two groups was not significant. In HHI group, similar effects were observed for the ADAS-Cog score compared to baseline (P = 0.001); instead, when ACDS-ADL was evaluated, no differences was observed among the three groups. These results remained unchanged also after adjustment for confounding variables (i.e. APOε-status, sex, BMI, education level, heart diseases and HbA1c). We suggest that higher IR-degree is associated with greater cognitive decline in diabetic patients; so we hypothesize that IR degree, more than IR status itself, could be related to the severity of cognitive impairment.

Indexed as

AgedCase-Control StudiesCognitive DysfunctionDiabetes MellitusFemaleFollow-Up StudiesHumansInsulin ResistanceItalyMaleMiddle AgedNeuropsychological TestsProspective StudiesAlzheimer diseaseCognitive impairmentInsulin resistance

Identifiers

PMID28229380
OpenAlexW2591171414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.